mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.3 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |